Probabilistic, not deterministic
Built around Monte Carlo simulation, sensitivity analysis, and probabilistic modeling. Handles uncertainty as a first-class input.
Planview • Enterprise software
Planview Advisor is Planview's product portfolio management tool for R&D and product development organizations making investment decisions under real uncertainty.
Merito sells Planview Advisor and delivers the product portfolio rollout: Monte Carlo modeling, sensitivity analysis, scenario planning, and the integration with the broader Planview portfolio for customers in pharma, life sciences, oil and gas, automotive, and R&D-heavy enterprises.
What it is
Planview Advisor is specifically designed for product portfolio management in industries where outcomes are uncertain and decisions are expensive: pharma drug pipelines, oil and gas exploration, automotive platform bets, and enterprise R&D investments. It is not a generic PMO tool. It is an investment decision platform with Monte Carlo simulation, probabilistic cost and schedule modeling, and tornado-diagram sensitivity analysis at its core.
Core capabilities cover standardized initiative valuation, what-if scenario analysis, trade-off and interdependency modeling, and risk aggregation across the portfolio. The product adds AI-powered optimization, intelligent resource forecasting, conversational project intelligence via Planview Anvi, and portfolio benchmarking against historical data.
Advisor is typically adopted alongside Planview Portfolios when a customer's strategic portfolio has a product or R&D investment dimension that Portfolios alone cannot model. It is a specialist tool; customers who do not need Monte Carlo or probabilistic modeling usually do not need Advisor.
Merito sells Planview Advisor and delivers the rollout: initiative valuation framework, scenario library design, Monte Carlo model configuration, integration with Portfolios and other Planview products, and enablement for R&D portfolio leaders, finance, and product strategy teams.
Ideal use cases
What it is best at
Built around Monte Carlo simulation, sensitivity analysis, and probabilistic modeling. Handles uncertainty as a first-class input.
Mature in pharma pipeline management, oil and gas exploration portfolios, and R&D investment decisions.
Automated portfolio optimization, intelligent resource forecasting, and conversational insights via Planview Anvi.
Pairs with Portfolios for enterprise SPM programs that have a product or R&D investment dimension.
Core capabilities
Standardized valuation and trade-off modeling across initiatives.
Standardized initiative valuation
Common valuation framework across initiatives for apples-to-apples comparison.
Portfolio optimization
AI-powered optimization identifying the highest-value portfolio composition under constraints.
Trade-off and interdependency modeling
Explicit dependency modeling for initiatives that block, enable, or compete with each other.
Probabilistic modeling for costs, schedules, and outcomes.
Monte Carlo simulation
Simulation across multiple distributions for cost, schedule, and value outcomes.
Sensitivity analysis and tornado diagrams
Identification of which variables most affect portfolio value.
Risk aggregation
Portfolio-level risk metrics aggregated from individual initiative risks.
Scenario-based forecasting
Forecast ranges for costs, schedules, and values under defined scenarios.
AI-assisted portfolio analysis.
Planview Anvi
Conversational AI for portfolio Q&A and scenario comparison.
Portfolio benchmarking
Benchmark against historical portfolio data for calibration.
Intelligent resource forecasting
AI-assisted capacity forecasting under uncertainty.
Where it fits in the stack
First-party integrations across the Planview portfolio.
Common data integration paths for Advisor.
Common custom integrations Merito builds around Advisor.
Deployment and implementation
Licensing and packaging
Planview Advisor
Single product with role-based user tiers for full users, contributors, and viewers.
Best for: R&D and product portfolio leaders in pharma, life sciences, oil and gas, automotive, and engineering-heavy enterprises.
Merito services
Merito sells licenses and the delivery work around them. Pick the service that matches where you are in the lifecycle.
Valuation framework, Monte Carlo model design, scenario library, and integration with Portfolios and data sources.
Explore service02Advisor integrated with delivery tools through Planview Hub for real R&D execution signal.
Explore service03Role-based training for R&D portfolio leaders, finance, and product strategy.
Explore service04Merito-placed Advisor administrators, Monte Carlo modelers, and R&D portfolio consultants.
Explore service05Ongoing admin support and model governance for Advisor footprints.
Explore serviceAdvisor licensing
Merito sells Planview Advisor and runs the Monte Carlo and scenario modeling rollout so portfolio decisions reflect real uncertainty.
Merito point of view
Advisor earns its seat when the portfolio has real uncertainty. Pharma pipelines, exploration economics, R&D investment decisions. In those domains, deterministic planning produces wildly wrong answers, and Monte Carlo plus sensitivity analysis is what separates a useful portfolio from a compliance exercise.
Outside those domains, Advisor is overkill. A SaaS SPM portfolio with clean schedule and cost data does not need Monte Carlo simulation. Customers who buy Advisor because "Portfolios does not handle uncertainty" usually discover that their actual uncertainty tolerance was lower than they thought, and the product sits underused. Merito's first Advisor conversation is a fit test, not a rollout scope.
When Advisor does fit, the rollout is more data engineering than product configuration. Initiative value and cost distributions need to come from real source systems, not spreadsheets. That is where most Advisor rollouts either succeed or quietly stall.
What buyers usually underestimate
Related from Merito
Related solutions
Related services
Related products
Frequently Asked Questions
Consultation request
Share your R&D or product portfolio shape and where Monte Carlo or sensitivity analysis would actually change a decision. A Merito Planview specialist follows up within one business day.
Fit test first
We start with a fit test. Advisor earns its seat when uncertainty is real; otherwise Portfolios is enough.
Data before models
Monte Carlo quality is set by data quality. We do integration and calibration before simulation.
Next step
A Merito Advisor engagement starts with distribution calibration for your real source-system data, then scenario design, then rollout.